Quantcast

Drugmakers pay $41.5 million to settle Vytorin suits (access required)

By: Nora Tooher
Published: August 6, 2009

Tags:

Merck & Co. and Schering-Plough Corp. said yesterday they will pay $41.5 million to settle lawsuits involving their cholesterol medication Vytorin. The suits claimed the drug makers violated state consumer protection laws by delaying unfavorable study results because they would hurt sales. Merck and Schering-Plough faced more than 140 class action lawsuits involving Vytorin.  Marketed jointly by ...
© Copyright 2012 Lawyers USA. All Rights Reserved.


POST A COMMENT

Sign-up for alerts

SUBSCRIBERS: Did you receive the new Lawyers USA Weekly Update in your inbox on Monday?

If not, click here to register and learn more now.


FEATURED PODCAST

Baby Boomer lawyers and retirement

Nelson Schwartz from The New York Times recently wrote an article titled, "Easing Out the Gray-Haired. Or Not.," spotlighting the fate of the Baby Boomer generation within law firms. Attorney and co-host Bob Ambrogi welcomes Attorney Valerie C. Samuels, a partner in the firm Posternak Blankstein & Lund LLP and co-chair of the Employment Law Group, and Attorney Roy Ginsburg, to take a look at this generation of baby boomers within law firms, retirement, their fate within the firm, options upon retirement and what this means for law firms: big, small and solo.

Click here to listen to the podcast.

Click here to download the podcast.

Click here for the Podcast archive.